Photo opp of his P3.5 billion vaccination program. Oops, the vaccine is revealed as having a frightening downside.
It would only be more than a year later, last November 29, that Sanofi itself announced this downside of its own drug: “For those not previously infected by dengue virus, however, more cases of severe disease could occur following (Dengvaxia) vaccination upon a subsequent dengue infection.” In layman’s terms, if a person had not contracted dengue before and is vaccinated with Dengvaxia, he will likely suffer a severe form of dengue, which could even be fatal.